Background

Human hearing and balance originate from the sophisticated structures of the inner ear, located deep within the temporal bone. Endolymph, which fills the cochlea and vestibular system, maintains a high concentration of potassium ions to facilitate electrical signal transmission in sensory hair cells. The key tissues responsible for creating this specialized fluid environment and maintaining pressure are the epithelial cells that constitute the endolymphatic ducts and sacs. If these cells lose their function and fluid homeostasis collapses, endolymphatic hydrops occurs, leading to sensorineural hearing loss or severe vertigo.

While numerous genetic variants causing inner ear malformations and congenital hearing loss have been identified, it remains unclear through which signaling pathways undifferentiated cells differentiate into endolymphatic epithelial cells during early development. Previous studies focused only on fragmentary expression patterns of individual transcription factors (TFs) and failed to comprehensively explain the interactions within the complex gene network. A significant limitation was the difficulty of directly tracking the cell fate determination process occurring during early mammalian embryonic development at the level of living human tissue.

The transcription factor SOX9 is expressed not only in cartilage formation but also during otic vesicle formation. Reports have continuously accumulated that single-nucleotide deletions or premature termination mutations of this gene are accompanied by auditory abnormalities. However, it had not been identified specifically which downstream pathways are disrupted by SOX9 defects to cause the functional collapse of the inner ear epithelium.

Key Findings

Researchers demonstrated the molecular circuit leading from SOX9 to Wnt and SOX10 by combining mouse genetic models with human pluripotent stem cell (hPSC)-derived inner ear organoids. A mechanism was observed where SOX9 in otic vesicle-derived progenitor cells directly binds to Wnt signaling pathway receptors and transcription factor promoters to pre-tune signaling sensitivity. Properly induced Wnt activity, in turn, controlled the transcriptional timing of SOX10, directing the final differentiation into endolymphatic sac epithelial cells responsible for ion transport.

Reproduction of the SOX9 mutation (SOX9 Y440X/+) identified in patients with hereditary hearing loss caused complete collapse of this regulatory axis. Mutant mice (Sox9 Y440X/+) lacking the C-terminal transcriptional activation domain showed widespread endolymphatic hydrops as endolymphatic sac formation was inhibited from embryonic day 14.5 (E14.5). In Auditory Brainstem Response (ABR) tests, the hearing threshold of mutant mice increased by an average of 48.5 dB compared to normal individuals, and rotational behavior due to severe vestibular dysfunction was observed.

The same pathological phenomenon was reproduced in human cell models. Human 3D inner ear organoids into which the SOX9 Y440X/+ heterozygous mutation was introduced via CRISPR gene editing showed a 64.2% decrease in the proportion of cells expressing key ion transport markers, ATP6V1B1 and pendrin (SLC26A4), compared to the normal control group. Abnormal hyperactivation of Wnt signaling was identified as the cause. It was confirmed that administering a small-molecule Wnt inhibitor at a specific differentiation time point restored the expression of the missing endolymphatic epithelial markers by more than 80%.

Significance and Outlook

This study organized the lineage differentiation trajectory of the inner ear endolymphatic epithelium, which had remained a developmental challenge, into a single unified molecular circuit. It clearly demonstrates that rather than the independent action of individual transcription factors, a feedback loop in which SOX9, Wnt, and SOX10 interact is crucial for maintaining homeostasis in sensory organs. The discovery of evolutionarily conserved circuits has laid the academic groundwork for understanding the molecular evolutionary processes underlying mammalian auditory development.

The achievement of perfectly simulating the pathological mechanism of hereditary hearing loss in vitro using a human stem cell-based organoid system is also noteworthy. Due to the low accessibility of the anatomical structures, research on the pathophysiology and drug screening for rare genetic diseases of the auditory and vestibular systems has been extremely limited. Utilizing disease-specific organoids enables the non-invasive prediction of inner ear abnormalities in patients with mutations and the screening of personalized compounds.

However, practical barriers remain to be resolved for clinical application. Due to the nature of the circuit where cell fate is determined in early fetal development, it is uncertain whether damaged epithelial tissue can be fully regenerated when artificial gene regulation or signaling pathway regulators are administered to patients diagnosed after birth. The development of advanced drug delivery systems capable of safely crossing the Blood-Labyrinth Barrier to reach the target sites in the inner ear must be pursued in parallel.